Study Group: Oncologists who Treat Leukemia (US)
Council Members in this Study Group: 202
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
- Eric Jacobsen
Instructor in Medicine
DANA-FARBER CANCER INSTITUTE, INC.
Eric Jacobsen, MD, is Medical Oncologist and Hematologist in the Hematology and Oncology Department at the Dana-Farber Cancer Institute in Boston, MA. Dr. Jacobsen is a member of the lymphoma and bone marrow transplant divisions at Dana-Farber Cancer...
- William Matsui
Associate Professor
Johns Hopkins University - CCWilliam Matsui, MD, is an Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center and the Johns Hopkins School of Medicine in Maryland, since July 2008. Dr. Matsui specializes in clinical and laboratory examination of hematological...
- Michael Grossbard
Professor of Clinical Medicine
Columbia University College of Physicians and SurgeonsMichael Grossbard, MD, is a Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons and the Chief of Hematology-Oncology at St. Luke's-Roosevelt Hospital and Beth Israel Medical Center in New York City. His clinical research...
Brian AbbottMedical Director of Hematology
Big Sky OncologyBrian Abbott, MD, is the Medical Director of Hematology at Big Sky Oncology (Benefis Health System) and Sletten Cancer Institute in Great Falls, Montana. He is also Medical Director of the Palliative Medicine program. Dr. Abbott's specialties include...
- Alan List
Executive Vice President and Physician-in-Chief
MOFFITT CANCER CENTERAlan List, MD, is an Executive Vice President and Physician-in-Chief at the Moffitt Cancer Center in Tampa, FL, since 2004. Dr. List is an expert in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Prior to his arrival at Moffitt in 2003,...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Avastin Raises Risk of Clots: New News?
December 1, 2008
Scientists recommend 'black box' for Avastin | www.fiercepharma.com
In pooled data from 8000 patients across 15 studies, the risk of blood clots was increased by 12% in patients receiving Avastin.
-
Amgen Rewords Label: Less Use of Procrit
August 29, 2008
Amgen Told to Reword Drug Label | www.nytimes.com
The FDA required Amgen to revise the label for Procrit and Aranesp so that these agents are not used until a patient's hemoglobin drops below 10 or in the setting of potentially curative therapy.
-
Transparency in Healthcare: How to Assess?
August 29, 2008
Transparency in Healthcare | www.hospitalimpact.org
The author argues that transparency in healthcare will be an important step forward for the consumer.
-
August 29, 2008
Costly Cancer Drug Offers Hope, but Also a Dilemma | www.nytimes.com
Avastin improves survival in colon cancer and lung cancer and improves progression free survival in breast cancer- clinically meaningful outcomes. Yet these gains are of relatively short duration and the cost of Avastin is significant- 50,000 to 100,000 dollars per year.
-
NICE States Novel Therapies for Renal Cell Cancer Too Costly
August 28, 2008
UK Says Kidney Cancer Drugs Are Too Pricey | www.pharmalot.com
NICE has stated that the cost of several novel agents for the treatment of renal cell cancer including Sutent, Torisel, Avastin, and Nexavar exceeds the benefit when assessed by quality adjusted life years (QALY) gained from the therapies.
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Office Based Private Practice or Clinic
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Physician - Director
- Physician - Division Head
- Director
Related Study Groups
GLG Live Meetings with this Study Group's Leading Experts (?)
December 11, 2007 | Atlanta
GLGi: Panel Review of the American Society of Hematology (ASH) 49th Annual MeetingGLG Webcasts & Teleconferences
Leading Experts in Oncologists who Treat Leukemia (US) have not participated in any GLG webcasts.